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Abstract 14 
 Objectives The aim of this work was to investigate the feasibility of producing darunavir (DRV) 15 
solid dispersion nanoparticles coated with an enteric polymer	  in one single step using electrospraying. 16 
 Methods The core-shell nanoparticles were made using coaxial electrospraying. A solution of 17 
DRV with hydroxypropyl methylcellulose (HPMC) in a mixture of organic solvents formed the core while 18 
the shell was produced from an enteric polymer (Eudragit L100) dissolved in an organic solvent. The final 19 
particles were evaluated in terms of morphology, physical state, encapsulation efficiency and in vitro 20 
dissolution. 21 
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 Key findings Nanoparticles of encapsulated DRV solid dispersions within Eudragit L100 were 1 
successfully prepared with high encapsulation efficiency (90%). The enteric coating layer reduced the 2 
percentage of DRV release in acidic medium in the in vitro dissolution test to less than 20%.     3 
 Conclusions This study showed the potential of coaxial electrospraying for encapsulating solid 4 
dispersions within core-shell structured nanoparticles.  5 
 6 
Introduction 7 
Formulation of solid dispersions (SDs) is one of the popular strategies to increase the oral 8 
bioavailability of poorly water-soluble drugs. [1] In an ideal SD, namely a glass solution, the active 9 
pharmaceutical ingredient (API) is dispersed at a molecular level within a hydrophilic carrier. However, in 10 
reality the API molecules very often form amorphous particles/clusters whose physical structure and 11 
dimensions depends highly on the preparation method. [2] In general, SDs can be produced by either 12 
solvent-based methods (e.g. spray-drying, film casting) or heat-based methods (e.g. hot melt extrusion, 13 
spray congealing). [3] The success of preparing a “complete” amorphous glass solution via traditional 14 
solvent-evaporation methods relies on a rapid rate of solvent removal. This is challenging because the 15 
increase in viscosity during the drying process will hamper further evaporation of the residual solvents. [4] 16 
Spray-drying is among the most commonly used processes for SDs preparation. The main advantage of 17 
this method is the high efficiency in solvent removal, but downstream/post-processing and stability of the 18 
spray-dried products are still challenging. Substantial variations in physicochemical properties of the final 19 
dosage forms are often encountered because of the hygroscopic behavior and poor flowability and 20 
compressibility of amorphous spray-dried SDs. [5] Moreover, amorphous SDs are physically unstable 21 
because they are often supersaturated systems with respect to thermodynamic solid state solubility. [6]  22 
Another challenge in pharmaceutics is coating of the API. An additional layer can be required 23 
either to protect unstable APIs in the stomach or to prevent injuries/irritation to the stomach, but also 24 
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when a targeted/controlled drug release at a specific site in the gastrointestinal tract is necessary. The 1 
coating process is particularly challenging for spray-dried powders consisting of small particles. [7] Kondo 2 
el al reported the preparation of sustained-release coated particles by using a three-fluid nozzle spray 3 
drying set-up. [8] A crystal suspension and a polymer solution were fed through a central and outer passage 4 
of the nozzle, respectively, resulting in the formation of polymer-coated crystalline microparticles. In the 5 
present study, we propose electrospraying as a novel process to prepare and coat nanoparticles of solid 6 
dispersions in one single step.  7 
Electrospraying can be placed in the group of solvent-based methods. However, it shows an 8 
advantage over other traditional solvent-evaporation methods in terms of solvent removal. This technique 9 
uses electrical forces to atomize solutions into droplets with diameters in the micro- or nanometer range. 10 
[9] The small size of these droplets allows rapid and complete solvent removal. Thus, on the way from the 11 
dispensing nozzle to the collector, the produced droplets dry and turn into solid particles. The droplet 12 
volume and hence the solid particle size depend on the solution composition and the resulting solution 13 
properties as well as the processing parameters. [10] In cases where an API solution is used, because of 14 
rapid removal of solvent, one could expect more “complete” amorphous SDs. Both amorphization and 15 
nanosizing by electrospraying will contribute to dissolution improvement of poorly water-soluble APIs. 16 
However, these are not the only advantages of electrospraying compared to the traditional solvent-based 17 
methods. Because of Coulomb repulsion of the charged particles, they are self-dispersing during their 18 
flight towards the collector, resulting in less coalescence of the dried particles. [11] Moreover, with an 19 
appropriate selection of solutions and process parameters, a narrow particle size distribution may be 20 
obtained. This leads to an additional benefit, as monodisperse particles are able to provide more regular 21 
and predictable drug release profiles. [12] The nano/micro-particles collected from electrospraying can also 22 
be further processed, e.g. as powders for reconstitution, a suitable dosage form for paediatric and elderly 23 
patients.  This dosage form could offer convenience in terms of use because the administered dose can be 24 
easily adapted to the needs of the patients, while the powders comprising nanoparticles can be 25 
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reconstituted to a drinkable and milky suspension which leaves no unpleasant and rough feeling in the 1 
mouth. Lastly, the electrospraying set-up can be adjusted to produce core-shell particles using nozzles that 2 
have two or more channels, so-called coaxial nozzles. Therefore, in this paper, we investigated the 3 
feasibility of electrospraying as a one-step process to prepare polymer-coated solid dispersion particles 4 
applying a coaxial electrospraying set-up. The resultant particles are core-shell structures with high 5 
encapsulation efficiency. 6 
Darunavir (DRV) was used as the poorly water-soluble model drug. Amorphous solid dispersion 7 
nanoparticles of DRV with hydroxypropyl methylcellulose (HPMC) were formed and coated 8 
simultaneously with Eudragit L100 by using coaxial electrospraying. The rationale for the preparation of 9 
coated DRV solid dispersion particles is their use in an advanced fixed dose combination with ritonavir 10 
(RTV) as suggested by the WHO. [13] In a previous study, we described how spray-dried ternary solid 11 
dispersions of DRV and RTV with HPMC showed a decrease in release of both RTV and DRV compared 12 
to binary spray-dried powders of either RTV or DRV, indicating that the simultaneous release of both 13 
DRV and RTV from the ternary spray-dried powders has a negative influence on the mutual solubility and 14 
the supersaturation behavior of DRV and RTV. [14] Therefore an “advanced” fixed dose combination of 15 
DRV and RTV should release RTV separately from DRV. Hence a system that releases RTV in the 16 
stomach and DRV later in the small intestine should serve this purpose. In order to achieve this, an enteric 17 
coating has to be applied to DRV solid dispersion particles.  18 
 19 
Materials and Methods 20 
Materials 21 
Darunavir, in the form of darunavir ethanolate was obtained from Cilag AG (Switzerland). 22 
Hydroxypropyl methylcellulose 2910 5mPa.s (HPMC) was provided by Corlocon (UK). Eudragit L100 23 
was obtained from Degussa Rohm GmbH (Germany). Absolute ethanol (EtOH) (AnalaR NORMAPUR®) 24 
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and isopropanol (IPA) were obtained from VWR (Belgium). Dichloromethane (DCM) and acetonitrile 1 
(HPLC grade) were obtained from Fisher Scientific (Belgium) and Acros Organic (Belgium), respectively. 2 
Hydroxypropyl methylcellulose phthalate (HPMCP) (grade 50) and hydroxypropyl methylcellulose 3 
acetate succinate (HPMCAS) (grade LF) were obtained from Acros Organic (Belgium). Other chemical 4 
reagents were of analytical grade. In all the experiments demineralized water (> 18 MΩ) (Maxima Ultra 5 
Pure Water, Elga Ltd, England) was used. 6 
Preparation of encapsulated DRV solid dispersion micro/nanoparticles by coaxial 7 
electrospraying 8 
Firstly, preliminary experiments with single-nozzle electrospraying were performed to screen for 9 
a suitable enteric polymer (HPMCP, HPMCAS and Eudragit L100) as well as the composition of mixture 10 
of organic solvents (DCM, EtOH and IPA) based on their response to different applied voltages. Then the 11 
core-shell particles of DRV were prepared by electrospraying using a two-concentric stainless steel nozzle 12 
(COAX_2DISP, Linari Engineering, Italy). The coaxial electrospray setup is illustrated in Figure 1. DRV 13 
and HPMC were dissolved in a mixture of DCM/IPA/EtOH (2/4/4 v/v/v) to obtain the inner/core solution. 14 
A solution of Eudragit L in IPA was used to form the particle shell. The electrospraying was performed in 15 
a climate-controlled electrospinning chamber (Electrospinning Apparatus EC-CLI, IME Technologies, the 16 
Netherlands) at 25 °C and 50% relative humidity. The solutions were delivered to the nozzles using two 17 
syringe pumps (PHD 4400, Harvard Apparatus, Massachusetts, US). The flow rates of the core and the 18 
shell solutions were varied and the applied voltage was adjusted accordingly (12-14 kV) to obtain a stable 19 
cone-jet mode. Each formulation (different ratio of core/shell flow rates) was prepared in duplicate. The 20 
distance between the tip of the nozzle and the collector was fixed at 6 cm. 10 ml of 0.1% (w/v) sodium 21 
lauryl sulfate solution in water (pH 4.5) was used as solution collector which was drawn in a homemade 22 
receiving dish consisting of an aluminum plate at the bottom and a wall made of Geberit high density 23 
polyethylene. At the end of the experiment, a milky suspension was obtained and the micro/nanoparticles 24 
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of DRV were isolated from the suspension by freeze-drying at -50°C and 0.04 mBar for 24 hour (Christ 1 
Alpha 1-2 LD plus freeze-dryer, SciQuip LTD, UK).    2 
 3 
Figure 1. Illustration of the coaxial electrospraying setup 4 
 5 
Encapsulation Efficiency Determination 6 
 Encapsulation efficiency (EE), the ratio of the mass of DRV effectively enclosed in particles to 7 
the total mass of drug available, was determined as follows: 1 ml of the final suspension collected after 8 
electrospraying was centrifuged at 14000 rpm and 21°C for 20 min (centrifuge 5804R, Eppendorf, 9 
Belgium) after which the sediment was rinsed with 1 ml of 0.1M HCl solution and then dissolved in 100 10 
ml of phosphate buffer at pH 6.8, whereas the supernatant and the above washing solution were filtered 11 
7 
 
through a PTFE membrane with 0.1µm pore size (WhatmanTM, GE Healthcare, UK). Drug adsorption to 1 
the filter membrane was ruled out in preliminary experiments. The amount of encapsulated DRV 2 
dissolved in phosphate buffer as well as the amount of free/non-entrapped DRV in the filtrate was 3 
determined by high pressure liquid chromatography (HPLC) analysis using an ODS Hypersil C18 reversed 4 
phase column (150 x 4.6 mm 5 µm) (Thermo Scientific, USA) connected to a Merk-Hitachi LaChrom 5 
system (Merck Darmstadt, Germany). The mobile phase was a mixture of 55:45 (v/v) acetonitrile: 10 mM 6 
sodium dihydrogen phosphate buffer (adjusted to pH 4.8 with 1M NaOH) used at a flow rate of 1 ml/min. 7 
20 µl of each samples was injected and the effluent was monitored at 245 nm. The calibration curve was 8 
linear in the range of 5 – 200 µM (R2 ≥ 0.999). Each sample was analyzed in duplicate. The EE was 9 
calculated according to the following equation: 10 
𝐸𝐸 =    𝑚!"#$%$𝑚!"#$%$ +𝑚!"## 𝑥100% 
where mloaded is the mass of encapsulated DRV and mfree is the mass of the free amount of DRV. 11 
In vitro drug release studies 12 
A weighed amount of the electrosprayed sample was transferred into a glass test tube containing 5 13 
ml of 0.1M HCl solution. The test tube then was rotated at 40 ± 2 rpm using a rotary mixer L26 (Labinco 14 
BV, Breda, The Netherlands) at room temperature. After 2 hours, 1 ml of the sample was taken and 15 
centrifuged at 14000 rpm for 20 min. The supernatant and the sediment were treated similarly to the 16 
process for the encapsulation efficiency test described above. The amount of DRV in the supernatant and 17 
in the sediment was then determined by the HPLC method described above. The percentage of drug 18 
release was calculated as the ratio of DRV dissolved in the supernatant to the total DRV in the sample. 19 
Each sample was analyzed in duplicate.  20 
Particle morphology 21 
8 
 
The morphology of the encapsulated DRV micro/nanoparticles in initial formulations (particles in 1 
collected suspension as such), after lyophilization as well as after dissolution testing in acidic medium was 2 
investigated to evaluate the influence of these processes on morphology changes. SEM pictures were 3 
recorded using a Phillips XL30 SEM-FEG (Philips, Eindhoven, The Netherlands) equipped with an 4 
Schottky field-emission electron gun. A beam of 15 kV was used and detection was performed using a 5 
conventional Everhart-Thornley secondary electron detector. The samples were affixed onto an aluminum 6 
stub with a double-sided adhesive carbon tape, and then coated with platinum under vacuum using a 7 
sputtering device (Balzers Union, Liechtenstein) before imaging.    8 
Particle size distribution 9 
Photon correlation spectroscopy (PCS) was used to investigate the average particle size as well as 10 
the particle size distribution (the polydispersity index) of the samples. Light scattering measurements were 11 
performed at a fixed angle of 90° on  a CGS-3 spectrometer (Malvern Instruments, Worcestershire, UK), 12 
equipped with a goniometer, a uniphase 22mV He–Ne laser operating at 632.8nm, an avalanche 13 
photodiode detector and an ALV-5000/EPP multiangle tau correlator. Because of the equipment 14 
unavailability, for each formulation, only batch 2 was used for PCS measurements. 15 
X-Ray Powder Diffraction (XRPD) 16 
 XRPD experiments were carried out at room temperature using an automated X’pert PRO 17 
diffractometer (PANalytical, Almelo, the Netherlands) with a Cu X-ray radiation source (Kα radiation, 18 
λ=0.1541874 nm). The operating conditions were 45 kV and 40 mA. The electrosprayed sample was 19 
placed between two Kapton® polyimide films (Chemplex® Industries Inc., Florida, USA) mounted to a 20 
sample holder plate. Measurements were performed in a continuous scan mode from 4° to 35° (2θ) with 21 
0.0167° step size and 200 s counting time.  22 
 23 
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Results and Discussion 1 
Screening formulation parameters for coaxial electrospraying  2 
In order to tune the processing conditions, screening experiments were performed using single-3 
nozzle electrospraying. A series of core solutions (DRV and HPMC) and shell solutions (different types of 4 
enteric polymers) in different solvents or mixture of solvents such as EtOH, DCM, IPA were prepared. 5 
The process parameters were adjusted in order to obtain a cone-jet mode operation as stable as possible. A 6 
stable cone-jet mode in electrospraying is of utmost importance to generate stable droplets with a mono-7 
disperse size distribution leading to a consistent particle morphology. [15] A single-nozzle was used at first 8 
instead of a coaxial nozzle to minimize the complexity of operation of spraying two separated liquids with 9 
different physical properties simultaneously. The operating window for stable electrospraying is normally 10 
very narrow and is highly dependent on the inter-related properties of the sprayed liquid, the process 11 
parameters and the environmental conditions. [16]  Thus the preliminary screening with single-nozzle 12 
would give an idea how the polymer solutions behave under electrical stress. Firstly, EtOH was selected 13 
for dissolving Eudragit L100, and a mixture of DCM: EtOH (50:50) was selected for dissolving HPMCP, 14 
HPMCAS and the core solution (DRV and HPMC). However, the cone-jet mode seemed to be unstable at 15 
a low concentration of 1% and the solutions dried too quick (jet disappeared at the tip of the nozzle edge). 16 
Lowering the applied voltage and/or increasing the polymer concentration (up to 5%) failed to maintain 17 
the cone-jet mode. Either the applied voltage was not high enough which resulted in too large droplets or 18 
the jet at the tip of the nozzle dried too fast. This could be attributed to the fact that both EtOH and DCM 19 
are volatile solvents (boiling temperature of 78.30C and 39.60C, respectively). Moreover EtOH is 20 
practically nonconductive and DCM has a low conductivity of 4.3 x 10-3 µS/m at 200C, respectively. 21 
Acetone was tried to replace EtOH and the mixture of EtOH: DCM as it is also recommended as a solvent 22 
for these polymers but the problem remained unchanged as acetone is also a volatile solvent (boiling point 23 
of 560C) although it has a significantly higher electrical conductivity (20 µS/m). The fact that the 24 
solubility of HPMCP and HPMCAS are limited to a few solvents prevented further investigation using 25 
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these polymers at this stage. In case of Eudragit L100, IPA was selected because this solvent has an 1 
acceptable electrical conductivity (6 µS/m) and more importantly, higher boiling point temperature 2 
(82.60C). IPA was also added into the mixture of EtOH and DCM to lower the vapour pressure of this 3 
mixture for preparing the core solution. With the presence of IPA, the cone-jet mode was easily obtained 4 
for both core and shell solution so in the next stage of the study, the solution of Eudragit L100 in IPA was 5 
used as the shell fluid and the solution of DRV with HPMC (weight ratio of 2:1) in a mixture of 6 
DCM/EtOH/IPA (2/4/4) was used as the core fluid in coaxial electrospraying.  7 
Preparation of encapsulated DRV nano/microparticles by coaxial electrospraying 8 
In the next series of experiments, the effect of polymer concentration on the spraying process and 9 
particles morphology was investigated. Three different concentrations of Eudragit L100 in IPA were 10 
tested (1, 3 and 5%). In all experiments, the flow rates of core/shell solution were kept constant (0.5 and 1 11 
ml/hour) but because of the difference in viscosity the applied voltage was slightly adapted (12 – 14 kV) 12 
to obtain a stable cone-jet mode.  The morphologies of these samples evaluated by SEM are presented in 13 
Fig 2. At a concentration of 1%, spherical particles with slightly wrinkled surface were observed. The 14 
particle size was uniform and smaller than 1µ. However, this low concentration of Eudragit L100 was not 15 
feasible because for a complete coating it required a very low ratio of core and shell flow rate which 16 
results in a low productivity/ efficiency. At higher concentration, up to 5%, the similar size of the particles 17 
obtained indicated that the concentration had little influence on the size. This could be partly credited to 18 
the slightly higher voltage applied for higher polymer concentration solutions. However, some collapsed 19 
and bigger particles were observed as well. The collapsed shape of these particles resulted most likely 20 
from trapped solvent in the core when they reached the collector. The later evaporation of the trapped 21 
solvents made particles collapse at the end. In other words, the shell solidified faster than the core and 22 
once the core dried, the particles lost this round shape. The fact this happened at a very high concentration 23 
(5%) supports this theory, because in this case more shell or more complete coating is expected, which 24 
will hinder the solvent evaporation from the core. Another important observation is that a lot of fibers 25 
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were formed, suggesting that the polymer concentration in this case was too high and electrospinning was 1 
taking place. During solidification of the droplets, polymer diffusion and/or chain entanglements also play 2 
an important role in determining the final morphology of the samples. [10] Chain entanglement obviously 3 
depends on polymer concentration and it was previously recommended that for successful electrospraying 4 
of particles, the highest possible concentration of polymer should be not larger than three times the critical 5 
concentration of overlap for lower molecular weights [17], and even lower for higher molecular weights of 6 
the polymer [18]. In case of Eudragit L100 3% solution, SEM analysis showed an acceptable result with 7 
less fiber and collapsed particles. The particle size distribution was quite narrow (about 1µm) so this 8 
solution was selected for further investigation. 9 
 10 
Figure 2. SEM pictures of the formulations using different Eudragit L 100 concentration as shell solution 11 
(a) 1%; (b) 5 %; (c) 3%  12 
 13 
Particles were, initially, collected on aluminum foil. However the yield was low because the 14 
samples were sticking to the aluminum foil. This was due to the fact that the particles were not dry enough 15 
or some solvent was still entrapped inside the particles when they were deposited on the collector. 16 
Changing the environmental conditions (increase of temperature and/or lower relative humidity) or 17 
increase of the distance between the nozzle and the metal collector could certainly be optimized but again 18 
this will influence the entire process e.g. field strength, evaporation rate as all the formulation and process 19 
parameters have a complex inter-dependence. Therefore, in this pilot study, which had the objective to 20 
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demonstrate the feasibility of electrospraying to prepare core-shell solid dispersion particles, we improved 1 
the yield by adapting the collector. The particles were collected in an aqueous solution using a homemade 2 
conductive cup. However, merely deionized water was not sufficient because the particles were not only 3 
very small but also coated with Eudragit L100, a hydrophobic polymer which made them float on the 4 
surface of the water. Replacing water with a 1% SLS aqueous solution improved the results as SLS, an 5 
anionic surfactant, lowers the interfacial tension and effectively wets the particles. Besides, to facilitate 6 
better dispersion of the particles in the solution, air was also pumped through two symmetric needles into 7 
the surface of the solution (Fig. 1). SEM pictures show that the particles collected in the solution before 8 
and after lyophilization have similar morphology and are comparable to the morphologies of the particles 9 
deposited on aluminum foil (Fig. 3).  10 
 11 
Figure 3. SEM pictures of the formulation F3 (a) collected from 0.1% SLS aqueous solution (b) after 12 
lyophilization (c) after dissolution 13 
 14 
Influence of the core/shell flow rate on the properties of encapsulated DRV particles prepared 15 
by coaxial electrospraying 16 
Five formulations (F1 to F5) with different ratio of core/shell flow rates were prepared. In all 17 
experiments, a 3% Eudragit L100 solution in IPA and DRV with HPMC solution in a mixture of DCM/ 18 
EtOH/IPA (2/4/4) was used as the shell and core solution, respectively. The applied voltage was slightly 19 
changed accordingly to obtain a stable cone-jet spraying mode; other parameters such as distance from the 20 
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nozzle to the collector and environmental conditions were kept constant. The details of these formulations 1 
are shown in Table 1.  2 
N° 
Flow rate 
(ml/h) 
Encapsulation Efficiency (%) 
Particle 
Size 
(nm) 
PDI 
Drug release in acidic medium 
(%) 
Core Shell Batch 1 Batch 2 Batch 1 Batch 2 
F1 0.8 1 85.59 (±0.9) 81.97 (±0.8) 1329 ± 290 0.48 ± 0.04 39.98 (±1.9) 45.56 (±2.4) 
F2 0.6 0.8 87.53 (±0.8) 84.49 (±0.6) 1396 ± 228 0.37 ± 0.06 36.62 (±2.1) 30.08 (±1.6) 
F3 0.8 1.2 87.89 (±1.1) 91.69 (±0.7) 1417 ± 139 0.42 ± 0.05 32.93 (±2.6) 28.77 (±2.3) 
F4 0.5 1 89.57 (±0.6) 93.71 (±1.1) 1187 ± 187 0.43 ± 0.05 20.31 (±1.7) 24.39 (±1.9) 
F5 0.3 1.2 94.35 (±0.8) 89.77 (±1.4) 1179 ± 99 0.37 ± 0.03 16.77 (±1.1) 19.97 (±1.5) 
 3 
Table 1. The influence of the ratio of core/shell flow rate on the properties of encapsulated DRV solid 4 
dispersion particles prepared by coaxial electrospraying (numbers in paratheses represent range of 5 
duplicate measurements). Particle size and PDI results were only collected to Batch 2. 6 
 7 
Particle size distribution by DLS 8 
All the samples had more or less similar sizes from 1 to 1.5 µm but as the ratio of core/shell flow 9 
rates decreased the size was reduced slightly (Table 1). One could argue that the more shell solution was 10 
sprayed the bigger the particles would be as a thicker coating polymer layer was expected. However, one  11 
should also take into consideration that the total solid sprayed in all samples was similar and that the 12 
initial droplets size, which is influenced by the viscosity of the sprayed fluid and the field strength, have a 13 
more important role in determining the size of the final dried particles.  The polydispersity indexes of all 14 
the samples were in a range of 0.3 to 0.5, which indicated a narrow particle size distribution. It seemed 15 
again that decreasing the ratio of core/shell flow rate lowered the polydispersity index, though the 16 
difference was negligible. Another interesting observation was that a negligible population of smaller 17 
particles of approximately 150 nm appeared in all samples (data not shown). The particle size results 18 
determined by DLS were in good agreement with SEM results as some particle fragments were observed 19 
surrounding bigger, spherical particles. The subpopulation of smaller particles is most likely resulting 20 
14 
 
from the Coulomb fission in a small fraction of the electrosprayed droplets before the polymer solidified. 1 
[19]  2 
Solid state characterization by XRD 3 
XRD was performed to characterize the amorphism/crystallinity of the drugs in the samples. As 4 
observed in Fig . 4, the presence of some distinct Bragg peaks in all samples indicate that a small portion 5 
of DRV in the samples was crystalline and not completely amorphous as expected. Incomplete 6 
amorphization during electrospraying has been reported previously. [20] However, in that case the model 7 
drug was griseofulvin, a very fast crystallizer [21] while DRV is a slower crystallizer. This indicated one 8 
probable problem associated to electrospraying as the amorphous drug has to undergo unfavorable 9 
conditions such as electrical stress which could induce crystallization. The authors also suggested a 10 
solution in form of an instantaneous post-heating of the formulation, but then there was a compromise of 11 
changing the surface of the particles. Another interesting observation was that these XRD patterns of the 12 
electrosprayed samples were slightly different to the one of crystalline DRV material as some new peaks 13 
arose. The original DRV material used for this study was an ethanolate form but it also exists as a hydrate 14 
when exposed to moderate or high relativity humidity as ethanol and water in lattice channels can readily 15 
exchange with one another. [22] During electrospraying, because of the evaporation of all the solvents, 16 
including EtOH, and the presence of water, DRV would crystallize, if anything, into hydrate crystals. 17 
However, the emergence of Bragg peaks at 4.5° and 20.4° (2θ) was not observed in the diffractograms of 18 
both ethanolate and hydrate crystals of DRV pointing a potential new form of DRV. The polymorphic 19 
modification was not further investigated in this study as it was beyond its scope.  20 
 21 
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 1 
Figure 4. Powder X-Ray diffractogram of encapsulated DRV solid dispersion particles prepared by 2 
coaxial electrospraying 3 
 4 
Encapsulation Efficiency 5 
As shown in Table 1, the encapsulation efficiency was slightly improved as the ratio of the 6 
core/shell flow rates decreased. It was expected because less core solution and more shell solution were 7 
sprayed which resulted in more complete coating. However, even in the case of very low core/shell flow 8 
rate (0.3/1.2 ml/hr), approximately 90% of DRV was encapsulated into the polymer shell layer. The 10% 9 
of free/uncoated DRV could generate a high initial burst release during dissolution. Dialysis can be used 10 
to reduce the concentration of free DRV, but in this feasibility study, it was not explored further.  11 
In vitro Dissolution Test 12 
16 
 
SEM analysis showed that the morphology of particles at the end of the dissolution test was 1 
similar to the ones collected after lyophilization (Fig. 3). The percentage of DRV release in acidic medium 2 
after 2 hours is shown in Table 1. In all samples, a high initial burst release was observed. The percentage 3 
of DRV release reached the maximum value within 10 min, which did not vary till the end of the 4 
experiment (2 hours). It was obvious that when the ratio of the core to shell flow rates decreased, DRV 5 
was released less in acidic medium because more polymer shell was sprayed compared to core material, 6 
leading to a thicker shell layer and more complete coating. The high burst release could be attributed to 7 
free/non encapsulated DRV in the samples as revealed in the encapsulation efficiency test as well as the 8 
very small particles in the nanosize range. However, when comparing the two formulations F1 and F5 9 
(largest difference in ratio of core/shell flow rates) with just approximately 10% difference in the 10 
encapsulation efficiency, the percentage of DRV release decreased considerably from 42% (F1) to 18% 11 
(F5). This showed that during the dissolution, DRV at the surface of “flawed” particles and even 12 
encapsulated DRV within core-shell structured particles could diffuse through the coating layer into the 13 
medium and almost immediately dissolved after that. This emphasizes the importance of a reasonable ratio 14 
of core/shell flow rates for a better coating layer, because if one simply keeps decreasing the ratio of 15 
core/shell flow rates, the amount of excipient weight fraction in dosage forms would be too high.       16 
Conclusion 17 
In this study, several parameters were investigated to prepare encapsulated DRV solid dispersion 18 
nanoparticles using coaxial electrospraying set-up. Provided the right solutions (type of polymer, 19 
concentration and solvents) and process variables (applied voltages) were selected, a solid dispersion of 20 
DRV was effectively prepared and coated with Eudragit L100 in one single step, though incomplete 21 
amorphization was observed by XRD. Encapsulation efficiency testing and in vitro dissolution tests 22 
showed that decreasing the ratio of the core/shell flow rates exhibited improvement in encapsulation 23 
efficiency and less drug release in acidic medium. This result suggested that coaxial electrospraying is a 24 
potential technique for encapsulating solid dispersions within core-shell structured nanoparticles. 25 
17 
 
However, further studies need to be done for better understanding of the interplay between formulation, 1 
process and equipment parameters. 2 
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